Corvus Pharmaceuticals Inc

NASDAQ:CRVS   3:59:43 PM EDT
3.87
-0.09 (-2.27%)
Products

Corvus Pharmaceuticals Announces Co-Founding Of Angel Pharmaceuticals In China

Published: 10/05/2020 17:16 GMT
Corvus Pharmaceuticals Inc (CRVS) - Corvus Pharmaceuticals Announces Co-founding of Angel Pharmaceuticals in China.
Corvus Pharmaceuticals Inc - Strategic Collaboration Gives Corvus 49.7% Equity Stake.
Corvus Pharmaceuticals - Angel Launches With $41 Million Financing Backed by Local Investor Group Which Includes 3 Biopharmaceutical Companies.
Corvus Pharmaceuticals - Angel Pharmaceuticals Will Be Responsible for Clinical Development & Commercialization of Licensed Pipeline Programs in China.
Corvus Pharmaceuticals - Angel Pharmaceuticals Plans to Initiate Clinical Trials in China for Ciforadenant, Cpi-006 & Cpi-818 in Next 12 -18 Months.
Corvus Pharmaceuticals Inc - Angel Pharmaceuticals' Cash Position at Launch is Expected to Provide Runway Beyond Its First Two Years.